La Jolla stock is getting creaned today (-22%) 2 days in front of the pdufa. Seems the bull case centers around the phase IV study, fda approves and ljp has the phase IV study to confirm. Opposite may be true, fda may not want to jeopardize phase IV by approving, esp a weak filing.
I expect an approvable letter and a final decision pending the phase IV outcome.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.